{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T23:59:35Z","timestamp":1698710375924},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":541,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1046\/j.1365-2230.2000.00651.x","type":"journal-article","created":{"date-parts":[[2003,5,13]],"date-time":"2003-05-13T08:58:34Z","timestamp":1052816314000},"page":"312-316","source":"Crossref","is-referenced-by-count":6,"title":["Detection of antigen-specific cytotoxic T lymphocytes: significance for investigative dermatology"],"prefix":"10.1093","volume":"25","author":[{"given":"G. S.","family":"Ogg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/248701a0","article-title":"Restriction of an in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within asyngeneic or semiallogeneic system","volume":"248","author":"Zinkernagel","year":"1974","journal-title":"Nature"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/329512a0","article-title":"The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens","volume":"329","author":"Bjorkman","year":"1987","journal-title":"Nature"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/329506a0","article-title":"Structure of the human class I histocompatibility antigen, HLA-A2","volume":"329","author":"Bjorkman","year":"1987","journal-title":"Nature"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.186.6.859","article-title":"Rapid effector function in CD8+ memory T cells","volume":"186","author":"Lalvani","year":"1997","journal-title":"J Exp Med"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1074-7613(00)80469-0","article-title":"Massive expansion of antigen-specific CD8+ T cells during an acute virus infection","volume":"8","author":"Butz","year":"1998","journal-title":"Immunity"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Direct visualization and phenotypic analysis of virus-specific T lymphocytes in HIV-infected individuals","volume":"274","author":"Altman","year":"1996","journal-title":"Science"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1126\/science.279.5359.2103","article-title":"Quantitation of HIV-specific CTL and plasma load of viral RNA","volume":"279","author":"Ogg","year":"1998","journal-title":"Science"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0952-7915(98)80110-6","article-title":"HLA-peptide tetrameric complexes","volume":"10","author":"Ogg","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.4049\/jimmunol.162.3.1827","article-title":"A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers","volume":"162","author":"Tan","year":"1999","journal-title":"J Immunol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1074-7613(00)80470-7","article-title":"Counting antigen-specific CD8 T cells: a re-evaluation of bystander activation during viral infection","volume":"8","author":"Murali-Krishna","year":"1998","journal-title":"Immunity"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0960-9822(98)70161-7","article-title":"Direct isolation, phenotyping and cloning of low frequency antigen-specific CTL from peripheral blood","volume":"8","author":"Dunbar","year":"1998","journal-title":"Current Biol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1097\/00002030-199910010-00032","article-title":"Isolation of HIV-specific CTL using HLA-coated beads","volume":"13","author":"Ogg","year":"1999","journal-title":"AIDS"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM199607043350118","article-title":"Massive infiltration of the skin by HIV-specific cytotoxic CD8+ T cells [letter]","volume":"335","author":"Bachelez","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1172\/JCI1450","article-title":"Oligoclonal expansion of HIV-specific cytotoxic CD8 T lymphocytes in the skin of HIV-1-infected patients with cutaneous pseudolymphoma","volume":"101","author":"Bachelez","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1172\/JCI1758","article-title":"Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes","volume":"101","author":"Koelle","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"Van der Bruggen","year":"1991","journal-title":"Science"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.178.2.489","article-title":"The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas","volume":"178","author":"Brichard","year":"1993","journal-title":"J Exp Med"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1084\/jem.188.9.1641","article-title":"Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen- experienced tumor-specific cytolytic T lymphocytes","volume":"188","author":"Romero","year":"1998","journal-title":"J Exp Med"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB19|cit19","first-page":"4050","article-title":"Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376","volume":"59","author":"Valmori","year":"1999","journal-title":"Cancer Res"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.190.5.651","article-title":"An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL) defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions","volume":"190","author":"Anichini","year":"1999","journal-title":"J Exp Med"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.1711700209","article-title":"An immunohistological study of cutaneous lymphocytes in vitiligo","volume":"170","author":"Badri","year":"1993","journal-title":"J Pathol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB22|cit22","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1056\/NEJM197709222971204","article-title":"Autoimmune vitiligo: detection of antibodies to melanin-producing cells","volume":"297","author":"Hertz","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(94)91709-4","article-title":"The role of tyrosinase in autoimmune vitiligo","volume":"344","author":"Song","year":"1994","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.1997.4781381.x","article-title":"Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2)","volume":"109","author":"Kemp","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1523-1747.ep12276556","article-title":"Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay","volume":"109","author":"Kemp","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1365-2133.1998.02503.x","article-title":"Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay","volume":"139","author":"Kemp","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2249.1998.00746.x","article-title":"Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA)","volume":"114","author":"Kemp","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB31|cit31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1523-1747.1999.00664.x","article-title":"Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo","volume":"113","author":"Kemp","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archderm.135.4.417","article-title":"Vitiligo antibodies are not directed to tyrosinase","volume":"135","author":"Xie","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000421-199612000-00017","article-title":"Melanoma-associated hypopigmentation: where are the antibodies?","volume":"19","author":"Merimsky","year":"1996","journal-title":"Am J Clin Oncol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.190.5.705","article-title":"High frequencies of naive Melan-A\/MART-1-specific CD8 (+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA) -A2 individuals","volume":"190","author":"Pittet","year":"1999","journal-title":"J Exp Med"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: a good prognostic sign","volume":"9","author":"Nordlund","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archderm.1987.01660320095019","article-title":"Prognostic significance of hypopigmentation in malignant melanoma","volume":"123","author":"Bystryn","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2230.1991.tb00383.x","article-title":"Prolonged survival in metastatic malignant melanoma associated with vitiligo","volume":"16","author":"Duhra","year":"1991","journal-title":"Clin Exp Dermatol"},{"key":"10.1046\/j.1365-2230.2000.00651.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI8943","article-title":"The arrival of HLA class II tetramers","volume":"104","author":"McMichael","year":"1999","journal-title":"J Clin Invest"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2230.2000.00651.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2230.2000.00651.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2230.2000.00651.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T04:08:53Z","timestamp":1682050133000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/25\/4\/312\/6627886"}},"subtitle":["Antigen-specific CTL in investigative dermatology"],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,7]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2230.2000.00651.x","archive":["Portico"],"relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}